Page 220 - Read Online
P. 220
oncogenes promote mouse ear regeneration by increasing the rate A, Lotz B, Melsheimer P, von Knebel Doeberitz M. Detection of
of wound re-epithelization and epidermal growth. J Invest Dermatol high-risk cervical intraepithelial neoplasia and cervical cancer by
2008;128:2894-903. amplification of transcripts derived from integrated papillomavirus
71. Klingelhutz AJ, Roman A. Cellular transformation by human oncogenes. Cancer Res 1999;59:6132-6.
papillomaviruses: lessons learned by comparing high- and low-risk 90. Li K, Jin X, Fang Y, Wang C, Gong M, Chen P, Liu J, Deng D, Ai
viruses. Virology 2012;424:77-98. J. Correlation between physical status of human papilloma virus
72. von Knebel Doeberitz M. New markers for cervical dysplasia and cervical carcinogenesis. J Huazhong Univ Sci Technol Med Sci
to visualise the genomic chaos created by aberrant oncogenic 2012;32:97-102.
papillomavirus infections. Eur J Cancer 2002;38:2229-42. 91. Baseman JG, Koutsky LA. The epidemiology of human
73. Moody CA, Laimins LA. Human papillomavirus oncoproteins: papillomavirus infections. J Clin Virol 2005;32 Suppl 1:S16-24.
pathways to transformation. Nat Rev Cancer 2010;10:550-60. 92. Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, von
74. Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen Knebel Doeberitz M. DNA aneuploidy and integration of human
J, Helin K. The H3K27me3 demethylase JMJD3 contributes to the papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia
activation of the INK4A-ARF locus in response to oncogene- and and invasive squamous cell carcinoma of the cervix uteri. Clin
stress-induced senescence. Genes Dev 2009;23:1171-6. Cancer Res 2004;10:3059-63.
75. Barradas M, Anderton E, Acosta JC, Li S, Banito A, Rodriguez- 93. Häfner N, Driesch C, Gajda M, Jansen L, Kirchmayr R, Runnebaum
Niedenführ M, Maertens G, Banck M, Zhou MM, Walsh MJ, Peters IB, Dürst M. Integration of the HPV16 genome does not invariably
G, Gil J. Histone demethylase JMJD3 contributes to epigenetic control result in high levels of viral oncogene transcripts. Oncogene
of INK4a/ARF by oncogenic RAS. Genes Dev 2009;23:1177-82. 2008;27:1610-7.
76. Gonzalez SL, Stremlau M, He X, Basile JR, Münger K. Degradation 94. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler
of the retinoblastoma tumor suppressor by the human papillomavirus CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de
type 16 E7 oncoprotein is important for functional inactivation Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U,
and is separable from proteasomal degradation of E7. J Virol Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F,
2001;75:7583-91. Wieting SL, Lehtinen MO, Dubin G; HPV PATRICIA study group.
77. Duensing S, Münger K. Mechanisms of genomic instability in Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle
human cancer: insights from studies with human papillomavirus vaccine against infection with human papillomavirus types 16 and
oncoproteins. Int J Cancer 2004;109:157-62. 18 in young women: an interim analysis of a phase III double-blind,
78. Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. randomised controlled trial. Lancet 2007;369:301-14.
Cancer Prev Res (Phila) 2012;5:18-23. 95. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter
79. Wikström A, Hedblad MA, Syrjänen S. Penile intraepithelial neoplasia: D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick
histopathological evaluation, HPV typing, clinical presentation and J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski
treatment. J Eur Acad Dermatol Venereol 2012;26:325-30. B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt
80. Silva RJ, Casseb J, Andreoli MA, Villa LL. Persistence and clearance K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV
of HPV from the penis of men infected and non-infected with HIV. J PATRICIA Study Group. Efficacy of human papillomavirus
Med Virol 2011;83:127-31. (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection
81. Szentirmay Z, Pólus K, Tamás L, Szentkuti G, Kurcsics J, Csernák E, and precancer caused by oncogenic HPV types (PATRICIA): final
Tóth E, Kásler M. Human papillomavirus in head and neck cancer: analysis of a double-blind, randomised study in young women.
molecular biology and clinicopathological correlations. Cancer Lancet 2009;374:301-14.
Metastasis Rev 2005;24:19-34. 96. Szarewski A, Poppe WA, Skinner SR, Wheeler CM, Paavonen J,
82. Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, Castellsagué
Morphological and immunohistochemical evidence suggesting X, Teixeira JC, Hedrick J, Jaisamrarn U, Limson G, Garland S,
human papillomavirus (HPV) involvement in oral squamous cell Romanowski B, Aoki FY, Schwarz TF, Bosch FX, Harper DM,
carcinogenesis. Int J Oral Surg 1983;12:418-24. Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G;
83. Harper DM, Demars LR. Primary strategies for HPV infection and HPV PATRICIA Study Group. Efficacy of the human papillomavirus
cervical cancer prevention. Clin Obstet Gynecol 2014;57:256-78. (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years
84. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, with and without serological evidence of previous exposure to HPV-
Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, 16/18. Int J Cancer 2012;131:106-16.
Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny 97. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J,
LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. One virus one lesion
Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M,Alemany - Individual components of CIN lesions contain a specific HPV type.
L, Albero G, Diaz M, de Sanjosé S. Comprehensive control of human J Pathol 2012;227:449-65.
papillomavirus infections and related diseases. Vaccine 2013;31 98. Gariglio P, Gutiérrez J, Cortés E, Vázquez J. The role of retinoid
Suppl 8:I1-31. deficiency and estrogens as cofactors in cervical cancer. Arch Med
85. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal Res 2009;40:449-65.
relation between human papillomavirus and cervical cancer. J Clin 99. Ding DC, Chiang MH, Lai HC, Hsiung CA, Hsieh CY, Chu TY.
Pathol 2002;55:244-65. Methylation of the long control region of HPV16 is related to the
86. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol
human papillomavirus infection and neoplasia. J Natl Cancer Inst 2009;147:215-29.
Monogr 2003:14-9. 100. van de Nieuwenhof HP, Massuger LF, van der Avoort IA, Bekkers
87. Wen LM, Estcourt CS, Simpson JM, Mindel A. Risk factors for the RL, Casparie M, Abma W, van Kempen LC, de Hullu JA. Vulvar
acquisition of genital warts: are condoms protective? Sex Transm squamous cell carcinoma development after diagnosis of VIN
Infect 1999;75:312-6. increases with age. Eur J Cancer 2009;45:851-6.
88. Münger K, Howley PM. Human papillomavirus immortalization and 101. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ,
transformation functions. Virus Res 2002;89:213-28. Solomon D; 2006 American Society for Colposcopy and Cervical
89. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider Pathology-sponsored Consensus Conference. 2006 consensus
210
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ June 15, 2016 ¦